Ostrum Asset Management »

Neurocrine Biosciences shares owned by Ostrum Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Ostrum Asset Management from 13F filings

Historical chart of Ostrum Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Ostrum Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Ostrum Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.9M 21k 137.92
2023-09-30 $3.3M 29k 112.50
2023-06-30 $2.5M 26k 94.30
2023-03-31 $2.6M 26k 101.22

More positions owned by Ostrum Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Amazon Common Stock (AMZN)
Spdr S&p 500 Etf Tr Exchange Traded Fund (SPY)
Meta Platforms Common Stock (META)
Johnson & Johnson Common Stock (JNJ)
Visa Common Stock (V)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
International Business Machs Common Stock (IBM)
Merck & Co Common Stock (MRK)
Unitedhealth Group Common Stock (UNH)
Eli Lilly & Co Common Stock (LLY)
Cencora Common Stock (COR)

View all positions for Ostrum Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Jpmorgan Chase & Co
Morgan Stanley
Bellevue Group
T. Rowe Price Associates
Geode Capital Management
Henderson Group
Dodge & Cox
Wellington Management Company
DSM Capital Partners
Brown Advisory Holdings Incorporated
Pictet Asset Management Holding SA
Rock Springs Capital Management
Armistice Capital

View all funds holding Neurocrine Biosciences